Treatment of Patients With RAD001 Who Have Progressive Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00767819
Recruitment Status : Completed
First Posted : October 7, 2008
Last Update Posted : October 5, 2017
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 17, 2017
  Actual Study Completion Date : May 17, 2017